Editors' Pick Small Molecule Amyloid-β Protein Precursor Processing Modulators Lower Amyloid-β Peptide Levels via cKit Signaling. Di Chen C-, Zeldich E, Khodr C, Camara K, Tung TYu, Lauder EC, Mullen P, Polanco TJ, Liu Y-Y, Zeldich D, et al. J Alzheimers Dis. 2019; 67(3):1089-1106. PMID: 30776010. Abstract Editors' Pick Two Year Outcomes, Cognitive and Behavioral Markers of Decline in Healthy, Cognitively Normal Older Persons with Global Deterioration Scale Stage 2 (Subjective Cognitive Decline with Impairment). Reisberg B, Torossian C, Shulman MB, Monteiro I, Boksay I, Golomb J, Benarous FGuillo, Ulysse A, Oo T, Vedvyas A, et al. J Alzheimers Dis. 2019; 67(2):685-705. PMID: 30689585. Abstract Editors' Pick Exercise Training on Locomotion in Patients with Alzheimer's Disease: A Feasibility Study. Pedrinolla A, Venturelli M, Fonte C, Munari D, Benetti MVittoria, Rudi D, Tamburin S, Muti E, Zanolla L, Smania N, et al. J Alzheimers Dis. 2018; 61(4):1599-1609. PMID: 29376858. Abstract Editors' Pick Mitochondrial Dysfunction as a Predictor and Driver of Alzheimer's Disease-Like Pathology in OXYS Rats. Tyumentsev MA, Stefanova NA, Muraleva NA, Rumyantseva YV, Kiseleva E, Vavilin VA, Kolosova NG J Alzheimers Dis. 2018; 63(3):1075-1088. PMID: 29710722. Abstract Editors' Pick Periodontal Pathogens and Associated Intrathecal Antibodies in Early Stages of Alzheimer's Disease. Laugisch O, Johnen A, Maldonado A, Ehmke B, Bürgin W, Olsen I, Potempa J, Sculean A, Duning T, Eick S J Alzheimers Dis. 2018; 66(1):105-114. PMID: 30223397. Abstract Editors' Pick Evaluation of Ocular Perfusion in Alzheimer's Disease Using Optical Coherence Tomography Angiography. Lahme L, Esser ELuisa, Mihailovic N, Schubert F, Lauermann J, Johnen A, Eter N, Duning T, Alnawaiseh M J Alzheimers Dis. 2018; 66(4):1745-1752. PMID: 30507577. Abstract Editors' Pick Evolvability of Amyloidogenic Proteins in Human Brain. Hashimoto M, Ho G, Sugama S, Takamatsu Y, Shimizu Y, Takenouchi T, Waragai M, Masliah E J Alzheimers Dis. 2018; 62(1):73-83. PMID: 29439348. Abstract Editors' Pick 18F-FDG PET for Prediction of Conversion to Alzheimer's Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy. Smailagic N, Lafortune L, Kelly S, Hyde C, Brayne C J Alzheimers Dis. 2018; 64(4):1175-1194. PMID: 30010119. Abstract Editors' Pick Increased Insoluble Amyloid-β Induces Negligible Cognitive Deficits in Old AppNL/NL Knock-In Mice. Salas IH, Callaerts-Vegh Z, D'Hooge R, Saido TC, Dotti CG, De Strooper B J Alzheimers Dis. 2018; 66(2):801-809. PMID: 30320577. Abstract Editors' Pick Distinct White Matter Changes Associated with Cerebrospinal Fluid Amyloid-β1-42 and Hypertension. Al-Janabi OM, Brown CA, Bahrani AA, Abner EL, Barber JM, Gold BT, Goldstein LB, Murphy RR, Nelson PT, Johnson NF, et al. J Alzheimers Dis. 2018; 66(3):1095-1104. PMID: 30400099. Abstract Pages123456789…next ›last »
Editors' Pick Two Year Outcomes, Cognitive and Behavioral Markers of Decline in Healthy, Cognitively Normal Older Persons with Global Deterioration Scale Stage 2 (Subjective Cognitive Decline with Impairment). Reisberg B, Torossian C, Shulman MB, Monteiro I, Boksay I, Golomb J, Benarous FGuillo, Ulysse A, Oo T, Vedvyas A, et al. J Alzheimers Dis. 2019; 67(2):685-705. PMID: 30689585. Abstract Editors' Pick Exercise Training on Locomotion in Patients with Alzheimer's Disease: A Feasibility Study. Pedrinolla A, Venturelli M, Fonte C, Munari D, Benetti MVittoria, Rudi D, Tamburin S, Muti E, Zanolla L, Smania N, et al. J Alzheimers Dis. 2018; 61(4):1599-1609. PMID: 29376858. Abstract Editors' Pick Mitochondrial Dysfunction as a Predictor and Driver of Alzheimer's Disease-Like Pathology in OXYS Rats. Tyumentsev MA, Stefanova NA, Muraleva NA, Rumyantseva YV, Kiseleva E, Vavilin VA, Kolosova NG J Alzheimers Dis. 2018; 63(3):1075-1088. PMID: 29710722. Abstract Editors' Pick Periodontal Pathogens and Associated Intrathecal Antibodies in Early Stages of Alzheimer's Disease. Laugisch O, Johnen A, Maldonado A, Ehmke B, Bürgin W, Olsen I, Potempa J, Sculean A, Duning T, Eick S J Alzheimers Dis. 2018; 66(1):105-114. PMID: 30223397. Abstract Editors' Pick Evaluation of Ocular Perfusion in Alzheimer's Disease Using Optical Coherence Tomography Angiography. Lahme L, Esser ELuisa, Mihailovic N, Schubert F, Lauermann J, Johnen A, Eter N, Duning T, Alnawaiseh M J Alzheimers Dis. 2018; 66(4):1745-1752. PMID: 30507577. Abstract Editors' Pick Evolvability of Amyloidogenic Proteins in Human Brain. Hashimoto M, Ho G, Sugama S, Takamatsu Y, Shimizu Y, Takenouchi T, Waragai M, Masliah E J Alzheimers Dis. 2018; 62(1):73-83. PMID: 29439348. Abstract Editors' Pick 18F-FDG PET for Prediction of Conversion to Alzheimer's Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy. Smailagic N, Lafortune L, Kelly S, Hyde C, Brayne C J Alzheimers Dis. 2018; 64(4):1175-1194. PMID: 30010119. Abstract Editors' Pick Increased Insoluble Amyloid-β Induces Negligible Cognitive Deficits in Old AppNL/NL Knock-In Mice. Salas IH, Callaerts-Vegh Z, D'Hooge R, Saido TC, Dotti CG, De Strooper B J Alzheimers Dis. 2018; 66(2):801-809. PMID: 30320577. Abstract Editors' Pick Distinct White Matter Changes Associated with Cerebrospinal Fluid Amyloid-β1-42 and Hypertension. Al-Janabi OM, Brown CA, Bahrani AA, Abner EL, Barber JM, Gold BT, Goldstein LB, Murphy RR, Nelson PT, Johnson NF, et al. J Alzheimers Dis. 2018; 66(3):1095-1104. PMID: 30400099. Abstract Pages123456789…next ›last »
Editors' Pick Exercise Training on Locomotion in Patients with Alzheimer's Disease: A Feasibility Study. Pedrinolla A, Venturelli M, Fonte C, Munari D, Benetti MVittoria, Rudi D, Tamburin S, Muti E, Zanolla L, Smania N, et al. J Alzheimers Dis. 2018; 61(4):1599-1609. PMID: 29376858. Abstract Editors' Pick Mitochondrial Dysfunction as a Predictor and Driver of Alzheimer's Disease-Like Pathology in OXYS Rats. Tyumentsev MA, Stefanova NA, Muraleva NA, Rumyantseva YV, Kiseleva E, Vavilin VA, Kolosova NG J Alzheimers Dis. 2018; 63(3):1075-1088. PMID: 29710722. Abstract Editors' Pick Periodontal Pathogens and Associated Intrathecal Antibodies in Early Stages of Alzheimer's Disease. Laugisch O, Johnen A, Maldonado A, Ehmke B, Bürgin W, Olsen I, Potempa J, Sculean A, Duning T, Eick S J Alzheimers Dis. 2018; 66(1):105-114. PMID: 30223397. Abstract Editors' Pick Evaluation of Ocular Perfusion in Alzheimer's Disease Using Optical Coherence Tomography Angiography. Lahme L, Esser ELuisa, Mihailovic N, Schubert F, Lauermann J, Johnen A, Eter N, Duning T, Alnawaiseh M J Alzheimers Dis. 2018; 66(4):1745-1752. PMID: 30507577. Abstract Editors' Pick Evolvability of Amyloidogenic Proteins in Human Brain. Hashimoto M, Ho G, Sugama S, Takamatsu Y, Shimizu Y, Takenouchi T, Waragai M, Masliah E J Alzheimers Dis. 2018; 62(1):73-83. PMID: 29439348. Abstract Editors' Pick 18F-FDG PET for Prediction of Conversion to Alzheimer's Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy. Smailagic N, Lafortune L, Kelly S, Hyde C, Brayne C J Alzheimers Dis. 2018; 64(4):1175-1194. PMID: 30010119. Abstract Editors' Pick Increased Insoluble Amyloid-β Induces Negligible Cognitive Deficits in Old AppNL/NL Knock-In Mice. Salas IH, Callaerts-Vegh Z, D'Hooge R, Saido TC, Dotti CG, De Strooper B J Alzheimers Dis. 2018; 66(2):801-809. PMID: 30320577. Abstract Editors' Pick Distinct White Matter Changes Associated with Cerebrospinal Fluid Amyloid-β1-42 and Hypertension. Al-Janabi OM, Brown CA, Bahrani AA, Abner EL, Barber JM, Gold BT, Goldstein LB, Murphy RR, Nelson PT, Johnson NF, et al. J Alzheimers Dis. 2018; 66(3):1095-1104. PMID: 30400099. Abstract Pages123456789…next ›last »
Editors' Pick Mitochondrial Dysfunction as a Predictor and Driver of Alzheimer's Disease-Like Pathology in OXYS Rats. Tyumentsev MA, Stefanova NA, Muraleva NA, Rumyantseva YV, Kiseleva E, Vavilin VA, Kolosova NG J Alzheimers Dis. 2018; 63(3):1075-1088. PMID: 29710722. Abstract Editors' Pick Periodontal Pathogens and Associated Intrathecal Antibodies in Early Stages of Alzheimer's Disease. Laugisch O, Johnen A, Maldonado A, Ehmke B, Bürgin W, Olsen I, Potempa J, Sculean A, Duning T, Eick S J Alzheimers Dis. 2018; 66(1):105-114. PMID: 30223397. Abstract Editors' Pick Evaluation of Ocular Perfusion in Alzheimer's Disease Using Optical Coherence Tomography Angiography. Lahme L, Esser ELuisa, Mihailovic N, Schubert F, Lauermann J, Johnen A, Eter N, Duning T, Alnawaiseh M J Alzheimers Dis. 2018; 66(4):1745-1752. PMID: 30507577. Abstract Editors' Pick Evolvability of Amyloidogenic Proteins in Human Brain. Hashimoto M, Ho G, Sugama S, Takamatsu Y, Shimizu Y, Takenouchi T, Waragai M, Masliah E J Alzheimers Dis. 2018; 62(1):73-83. PMID: 29439348. Abstract Editors' Pick 18F-FDG PET for Prediction of Conversion to Alzheimer's Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy. Smailagic N, Lafortune L, Kelly S, Hyde C, Brayne C J Alzheimers Dis. 2018; 64(4):1175-1194. PMID: 30010119. Abstract Editors' Pick Increased Insoluble Amyloid-β Induces Negligible Cognitive Deficits in Old AppNL/NL Knock-In Mice. Salas IH, Callaerts-Vegh Z, D'Hooge R, Saido TC, Dotti CG, De Strooper B J Alzheimers Dis. 2018; 66(2):801-809. PMID: 30320577. Abstract Editors' Pick Distinct White Matter Changes Associated with Cerebrospinal Fluid Amyloid-β1-42 and Hypertension. Al-Janabi OM, Brown CA, Bahrani AA, Abner EL, Barber JM, Gold BT, Goldstein LB, Murphy RR, Nelson PT, Johnson NF, et al. J Alzheimers Dis. 2018; 66(3):1095-1104. PMID: 30400099. Abstract Pages123456789…next ›last »
Editors' Pick Periodontal Pathogens and Associated Intrathecal Antibodies in Early Stages of Alzheimer's Disease. Laugisch O, Johnen A, Maldonado A, Ehmke B, Bürgin W, Olsen I, Potempa J, Sculean A, Duning T, Eick S J Alzheimers Dis. 2018; 66(1):105-114. PMID: 30223397. Abstract Editors' Pick Evaluation of Ocular Perfusion in Alzheimer's Disease Using Optical Coherence Tomography Angiography. Lahme L, Esser ELuisa, Mihailovic N, Schubert F, Lauermann J, Johnen A, Eter N, Duning T, Alnawaiseh M J Alzheimers Dis. 2018; 66(4):1745-1752. PMID: 30507577. Abstract Editors' Pick Evolvability of Amyloidogenic Proteins in Human Brain. Hashimoto M, Ho G, Sugama S, Takamatsu Y, Shimizu Y, Takenouchi T, Waragai M, Masliah E J Alzheimers Dis. 2018; 62(1):73-83. PMID: 29439348. Abstract Editors' Pick 18F-FDG PET for Prediction of Conversion to Alzheimer's Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy. Smailagic N, Lafortune L, Kelly S, Hyde C, Brayne C J Alzheimers Dis. 2018; 64(4):1175-1194. PMID: 30010119. Abstract Editors' Pick Increased Insoluble Amyloid-β Induces Negligible Cognitive Deficits in Old AppNL/NL Knock-In Mice. Salas IH, Callaerts-Vegh Z, D'Hooge R, Saido TC, Dotti CG, De Strooper B J Alzheimers Dis. 2018; 66(2):801-809. PMID: 30320577. Abstract Editors' Pick Distinct White Matter Changes Associated with Cerebrospinal Fluid Amyloid-β1-42 and Hypertension. Al-Janabi OM, Brown CA, Bahrani AA, Abner EL, Barber JM, Gold BT, Goldstein LB, Murphy RR, Nelson PT, Johnson NF, et al. J Alzheimers Dis. 2018; 66(3):1095-1104. PMID: 30400099. Abstract Pages123456789…next ›last »
Editors' Pick Evaluation of Ocular Perfusion in Alzheimer's Disease Using Optical Coherence Tomography Angiography. Lahme L, Esser ELuisa, Mihailovic N, Schubert F, Lauermann J, Johnen A, Eter N, Duning T, Alnawaiseh M J Alzheimers Dis. 2018; 66(4):1745-1752. PMID: 30507577. Abstract Editors' Pick Evolvability of Amyloidogenic Proteins in Human Brain. Hashimoto M, Ho G, Sugama S, Takamatsu Y, Shimizu Y, Takenouchi T, Waragai M, Masliah E J Alzheimers Dis. 2018; 62(1):73-83. PMID: 29439348. Abstract Editors' Pick 18F-FDG PET for Prediction of Conversion to Alzheimer's Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy. Smailagic N, Lafortune L, Kelly S, Hyde C, Brayne C J Alzheimers Dis. 2018; 64(4):1175-1194. PMID: 30010119. Abstract Editors' Pick Increased Insoluble Amyloid-β Induces Negligible Cognitive Deficits in Old AppNL/NL Knock-In Mice. Salas IH, Callaerts-Vegh Z, D'Hooge R, Saido TC, Dotti CG, De Strooper B J Alzheimers Dis. 2018; 66(2):801-809. PMID: 30320577. Abstract Editors' Pick Distinct White Matter Changes Associated with Cerebrospinal Fluid Amyloid-β1-42 and Hypertension. Al-Janabi OM, Brown CA, Bahrani AA, Abner EL, Barber JM, Gold BT, Goldstein LB, Murphy RR, Nelson PT, Johnson NF, et al. J Alzheimers Dis. 2018; 66(3):1095-1104. PMID: 30400099. Abstract Pages123456789…next ›last »
Editors' Pick Evolvability of Amyloidogenic Proteins in Human Brain. Hashimoto M, Ho G, Sugama S, Takamatsu Y, Shimizu Y, Takenouchi T, Waragai M, Masliah E J Alzheimers Dis. 2018; 62(1):73-83. PMID: 29439348. Abstract Editors' Pick 18F-FDG PET for Prediction of Conversion to Alzheimer's Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy. Smailagic N, Lafortune L, Kelly S, Hyde C, Brayne C J Alzheimers Dis. 2018; 64(4):1175-1194. PMID: 30010119. Abstract Editors' Pick Increased Insoluble Amyloid-β Induces Negligible Cognitive Deficits in Old AppNL/NL Knock-In Mice. Salas IH, Callaerts-Vegh Z, D'Hooge R, Saido TC, Dotti CG, De Strooper B J Alzheimers Dis. 2018; 66(2):801-809. PMID: 30320577. Abstract Editors' Pick Distinct White Matter Changes Associated with Cerebrospinal Fluid Amyloid-β1-42 and Hypertension. Al-Janabi OM, Brown CA, Bahrani AA, Abner EL, Barber JM, Gold BT, Goldstein LB, Murphy RR, Nelson PT, Johnson NF, et al. J Alzheimers Dis. 2018; 66(3):1095-1104. PMID: 30400099. Abstract Pages123456789…next ›last »
Editors' Pick 18F-FDG PET for Prediction of Conversion to Alzheimer's Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy. Smailagic N, Lafortune L, Kelly S, Hyde C, Brayne C J Alzheimers Dis. 2018; 64(4):1175-1194. PMID: 30010119. Abstract Editors' Pick Increased Insoluble Amyloid-β Induces Negligible Cognitive Deficits in Old AppNL/NL Knock-In Mice. Salas IH, Callaerts-Vegh Z, D'Hooge R, Saido TC, Dotti CG, De Strooper B J Alzheimers Dis. 2018; 66(2):801-809. PMID: 30320577. Abstract Editors' Pick Distinct White Matter Changes Associated with Cerebrospinal Fluid Amyloid-β1-42 and Hypertension. Al-Janabi OM, Brown CA, Bahrani AA, Abner EL, Barber JM, Gold BT, Goldstein LB, Murphy RR, Nelson PT, Johnson NF, et al. J Alzheimers Dis. 2018; 66(3):1095-1104. PMID: 30400099. Abstract Pages123456789…next ›last »
Editors' Pick Increased Insoluble Amyloid-β Induces Negligible Cognitive Deficits in Old AppNL/NL Knock-In Mice. Salas IH, Callaerts-Vegh Z, D'Hooge R, Saido TC, Dotti CG, De Strooper B J Alzheimers Dis. 2018; 66(2):801-809. PMID: 30320577. Abstract Editors' Pick Distinct White Matter Changes Associated with Cerebrospinal Fluid Amyloid-β1-42 and Hypertension. Al-Janabi OM, Brown CA, Bahrani AA, Abner EL, Barber JM, Gold BT, Goldstein LB, Murphy RR, Nelson PT, Johnson NF, et al. J Alzheimers Dis. 2018; 66(3):1095-1104. PMID: 30400099. Abstract Pages123456789…next ›last »
Editors' Pick Distinct White Matter Changes Associated with Cerebrospinal Fluid Amyloid-β1-42 and Hypertension. Al-Janabi OM, Brown CA, Bahrani AA, Abner EL, Barber JM, Gold BT, Goldstein LB, Murphy RR, Nelson PT, Johnson NF, et al. J Alzheimers Dis. 2018; 66(3):1095-1104. PMID: 30400099. Abstract Pages123456789…next ›last »
